Boron-Based Inhibitors of the NLRP3 Inflammasome

Autor: Baldwin, Alex, Rivers-Auty, Jack, Daniels, Michael, White, Claire, Schwalbe, Carl H., Schilling, T., Hammadi, Halah, Jaiyong, Panichakorn, Spencer, Nicholas G., England, Hazel, Luheshi, Nadia M., Kadirvel, Manikandan, Lawrence, Catherine B., Rothwell, Nancy, Harte, Michael, Bryce, Richard, Allen, Stuart, Eder, Claudia, Freeman, Sally, Brough, David
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Zdroj: Cell Chemical Biology
Baldwin, A, Rivers-Auty, J, Daniels, M, White, C, Schwalbe, C H, Schilling, T, Hammadi, H, Jaiyong, P, Spencer, N G, England, H, Luheshi, N M, Kadirvel, M, Lawrence, C B, Rothwell, N, Harte, M, Bryce, R, Allen, S, Eder, C, Freeman, S & Brough, D 2017, ' Boron based inhibitors of the NLRP3 inflammasome ', Cell Chemical Biology, vol. 24, no. 11, pp. 1321-1335 . https://doi.org/10.1016/j.chembiol.2017.08.011
ISSN: 2451-9456
DOI: 10.1016/j.chembiol.2017.08.011
Popis: Summary NLRP3 is a receptor important for host responses to infection, yet is also known to contribute to devastating diseases such as Alzheimer's disease, diabetes, atherosclerosis, and others, making inhibitors for NLRP3 sought after. One of the inhibitors currently in use is 2-aminoethoxy diphenylborinate (2APB). Unfortunately, in addition to inhibiting NLRP3, 2APB also displays non-selective effects on cellular Ca2+ homeostasis. Here, we use 2APB as a chemical scaffold to build a series of inhibitors, the NBC series, which inhibit the NLRP3 inflammasome in vitro and in vivo without affecting Ca2+ homeostasis. The core chemical insight of this work is that the oxazaborine ring is a critical feature of the NBC series, and the main biological insight the use of NBC inhibitors led to was that NLRP3 inflammasome activation was independent of Ca2+. The NBC compounds represent useful tools to dissect NLRP3 function, and may lead to oxazaborine ring-containing therapeutics.
Graphical Abstract
Highlights • New inhibitors of the NLRP3 inflammasome are described • NLRP3 inflammasome activation is independent of Ca2+ • These new inflammasome inhibitors are effective in vivo • The inhibitors described may lead to the development of new drugs
The NLRP3 inflammasome is known to contribute to damaging inflammation during disease. Baldwin et al. describe a new boron-containing series of inflammasome inhibitors, which may lead to the development of new anti-inflammatory molecules and allow further interrogation of inflammatory mechanisms.
Databáze: OpenAIRE